Hanau, Germany

Klause Thiemer


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Klause Thiemer: Innovator in Blood Pressure Research

Introduction

Klause Thiemer is a notable inventor based in Hanau, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with therapeutic potential. His work focuses on the synthesis of maleic acid half-amides, which exhibit unique biological activities.

Latest Patents

Thiemer's most recent patent involves the creation of maleic acid half-amides that possess blood pressure-raising activity. The patent details the preparation of half-amides of unsaturated aliphatic dicarboxylic acids, where various substituents can be introduced to modify their properties. These compounds not only have the potential to raise blood pressure but also demonstrate antidepressant activity, showcasing their dual therapeutic benefits.

Career Highlights

Thiemer is associated with Deutsche Gold- und Silber-Scheideanstalt Vormals Roessler, a company known for its expertise in precious metals and chemical research. His work at this institution has allowed him to explore innovative solutions in the pharmaceutical domain. With a patent portfolio that includes 1 patent, Thiemer continues to contribute to advancements in medicinal chemistry.

Collaborations

Throughout his career, Thiemer has collaborated with esteemed colleagues such as Karl H. Kingler and Fritz Stroman. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in their respective fields.

Conclusion

Klause Thiemer stands out as an inventor whose work in the synthesis of maleic acid half-amides has the potential to impact the medical field significantly. His innovative approach to developing compounds with both blood pressure-raising and antidepressant activities highlights the importance of research in creating effective therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…